87 related articles for article (PubMed ID: 16102578)
1. Identification of inactivating mutations in the JAK1, SYNJ2, and CLPTM1 genes in prostate cancer cells using inhibition of nonsense-mediated decay and microarray analysis.
Rossi MR; Hawthorn L; Platt J; Burkhardt T; Cowell JK; Ionov Y
Cancer Genet Cytogenet; 2005 Sep; 161(2):97-103. PubMed ID: 16102578
[TBL] [Abstract][Full Text] [Related]
2. Par-3 partitioning defective 3 homolog (C. elegans) and androgen-induced prostate proliferative shutoff associated protein genes are mutationally inactivated in prostate cancer cells.
Kunnev D; Ivanov I; Ionov Y
BMC Cancer; 2009 Sep; 9():318. PubMed ID: 19737411
[TBL] [Abstract][Full Text] [Related]
3. Identifying candidate colon cancer tumor suppressor genes using inhibition of nonsense-mediated mRNA decay in colon cancer cells.
Ivanov I; Lo KC; Hawthorn L; Cowell JK; Ionov Y
Oncogene; 2007 May; 26(20):2873-84. PubMed ID: 17086209
[TBL] [Abstract][Full Text] [Related]
4. Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay.
Bloethner S; Mould A; Stark M; Hayward NK
Genes Chromosomes Cancer; 2008 Dec; 47(12):1076-85. PubMed ID: 18677770
[TBL] [Abstract][Full Text] [Related]
5. NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer.
Wolf M; Edgren H; Muggerud A; Kilpinen S; Huusko P; Sørlie T; Mousses S; Kallioniemi O
Cell Oncol; 2005; 27(3):169-73. PubMed ID: 16037637
[TBL] [Abstract][Full Text] [Related]
6. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Huusko P; Ponciano-Jackson D; Wolf M; Kiefer JA; Azorsa DO; Tuzmen S; Weaver D; Robbins C; Moses T; Allinen M; Hautaniemi S; Chen Y; Elkahloun A; Basik M; Bova GS; Bubendorf L; Lugli A; Sauter G; Schleutker J; Ozcelik H; Elowe S; Pawson T; Trent JM; Carpten JD; Kallioniemi OP; Mousses S
Nat Genet; 2004 Sep; 36(9):979-83. PubMed ID: 15300251
[TBL] [Abstract][Full Text] [Related]
7. Identification and selective degradation of neopeptide-containing truncated mutant proteins in the tumors with high microsatellite instability.
Kim WK; Park M; Park M; Kim YJ; Shin N; Kim HK; You KT; Kim H
Clin Cancer Res; 2013 Jul; 19(13):3369-82. PubMed ID: 23674496
[TBL] [Abstract][Full Text] [Related]
8. PRRT2 truncated mutations lead to nonsense-mediated mRNA decay in Paroxysmal Kinesigenic Dyskinesia.
Wu L; Tang HD; Huang XJ; Zheng L; Liu XL; Wang T; Wang JY; Cao L; Chen SD
Parkinsonism Relat Disord; 2014 Dec; 20(12):1399-404. PubMed ID: 25457817
[TBL] [Abstract][Full Text] [Related]
9. A strategy for disease gene identification through nonsense-mediated mRNA decay inhibition.
Noensie EN; Dietz HC
Nat Biotechnol; 2001 May; 19(5):434-9. PubMed ID: 11329012
[TBL] [Abstract][Full Text] [Related]
10. Manipulation of nonsense mediated decay identifies gene mutations in colon cancer Cells with microsatellite instability.
Ionov Y; Nowak N; Perucho M; Markowitz S; Cowell JK
Oncogene; 2004 Jan; 23(3):639-45. PubMed ID: 14737099
[TBL] [Abstract][Full Text] [Related]
11. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts.
Vlietstra RJ; van Alewijk DC; Hermans KG; van Steenbrugge GJ; Trapman J
Cancer Res; 1998 Jul; 58(13):2720-3. PubMed ID: 9661880
[TBL] [Abstract][Full Text] [Related]
12. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
13. Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer.
Yano S; Matsuyama H; Hirata H; Inoue R; Matsumoto H; Ohmi C; Miura K; Shirai M; Iizuka N; Naito K
Oncol Rep; 2006 Jun; 15(6):1453-60. PubMed ID: 16685379
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
15. Nonsense-mediated mRNA decay was demonstrated in two hypofibrinogenemias caused by heterozygous nonsense mutations of FGG, Shizuoka III and Kanazawa II.
Soya K; Takezawa Y; Okumura N; Terasawa F
Thromb Res; 2013 Oct; 132(4):465-70. PubMed ID: 24011387
[TBL] [Abstract][Full Text] [Related]
16. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression.
Dunn GP; Sheehan KC; Old LJ; Schreiber RD
Cancer Res; 2005 Apr; 65(8):3447-53. PubMed ID: 15833880
[TBL] [Abstract][Full Text] [Related]
17. Identification of frequently mutated genes with relevance to nonsense mediated mRNA decay in the high microsatellite instability cancers.
Shin N; You KT; Lee H; Kim WK; Song M; Choi HJ; Rhee H; Nam SW; Kim H
Int J Cancer; 2011 Jun; 128(12):2872-80. PubMed ID: 20824714
[TBL] [Abstract][Full Text] [Related]
18. [Gene expression profiles of protein kinases and phosphatases obtained by hybridization with cDNA arrays: molecular portrait of human prostate carcinoma].
Kniazev IuP; Cheburkin IuV; Spikermann K; Peter S; Jenster G; Bangma KH; Karelin MI; Shkol'nik MI; Urbanskiĭ AI; Evtushenko VI; Ullrich A; Kniazev PG
Mol Biol (Mosk); 2003; 37(1):97-111. PubMed ID: 12624952
[TBL] [Abstract][Full Text] [Related]
19. Functional epigenomics identifies genes frequently silenced in prostate cancer.
Lodygin D; Epanchintsev A; Menssen A; Diebold J; Hermeking H
Cancer Res; 2005 May; 65(10):4218-27. PubMed ID: 15899813
[TBL] [Abstract][Full Text] [Related]
20. Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.
Ren B; Yu YP; Tseng GC; Wu C; Chen K; Rao UN; Nelson J; Michalopoulos GK; Luo JH
J Natl Cancer Inst; 2007 Jun; 99(11):868-80. PubMed ID: 17551147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
